glp-1 breast cancer glp 1 risk of Receptor Agonists in Cancer: A New Frontier in Obesity and Prognosis Management Breaking research on GLP-1s and – GLP-1 Receptor Agonists in Breast

Available from: Accessed on 29/09/2025

doi: 10.1126/sciadv.adp7171 442 WangB.LinP.ZhongY.TanX.ShenY.HuangY.et al

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Weight loss injections such as semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) work by mimicking a hormone that helps curb hunger and increase feelings of fullness after eating

Sometimes you may not feel obvious hunger signals until its too late and you begin to experience negative side effects

It also improves and enhances sleep quality and supports heart health

It has been studied for its potential benefits in conditions such as Alzheimers disease, age-related cognitive decline, and other neurological disorders